Vietnam over the counter (OTC) drugs market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of expanding pharmaceutical industry of the country. Vietnam healthcare industry does not have the capable resources for consistent research and advancement in the drug designing, pharmacy advancing, etc. Therefore, the local pharmaceutical manufacturers and contract manufacturing organizations are solely invested in manufacturing of generics, biosimilars and over the counter (OTC) drugs, thus driving the growth of the Vietnam over the counter (OTC) drugs market in the upcoming five years.

Over the counter (OTC) drugs are the non-prescription based medicines that are usually sold without any legal prescription and are often with no side effects. These drugs are safe and do not have any addictive nature if consumed un-monitored or without physicians prescription. Although, as a general awareness the physicians often advise to consult doctors and experts regarding illness before self-prescribing any kind of medicine. Basic cold medicines, vitamin tablets, or health supplements are different categories of over the counter (OTC) drugs.

Expanding Pharmaceutical Industry Satisfies Demand

Demands for the over the counter (OTC) drugs is expediting due to rapid demands from the common population of the country. Although, due to increasing population that is able to spend more on branded drugs and new advanced medicine, still a large portion of total population, exceeding 98 million population is inclined toward generic drugs, OTC drugs, and biosimilars. The growing pharmaceutical industry is also stabilized due to consistent flow of investments in the form of government financial assists.

In the year, 2018 Vietnam pharmaceutical industry was valued at USD5.34billion. In fact, industrial production index in the year exceeded 121.8 in the year 2020, demonstrating higher production and manufacturing of the pharmaceutical products like OTC drugs, thus substantiating the growth of the Vietnam OTC drugs market in the future five years.


Click here to download the sample

Market Segmentation

The Vietnam over the counter (OTC) drugs market is segmented by product, route of administration, dosage forms, distribution channel, competitional landscape, and regional distribution. Based on product, the market is further segmented into cough, cold and flu; vitamins, mineral, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. The market is also fragmented on the basis of route of administration of the drugs into oral, topical, and parenteral. Based on dosage form, the market is bifurcated into tablets, capsules, liquids & solution, creams/ lotions/ ointments, and others. By distribution channel, the market is differentiated into retail pharmacy, hospital pharmacy, and e-pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Northern region, Central region, and the Southern region.  

Company Profile

Sanofi-Aventis Vietnam Company, GlaxoSmithKline Vietnam, Reckitt Benckiser Vietnam, Imexpharm Pharmaceutical Joint Stock Company, DHG Pharmaceutical Joint Stock Company, Traphaco Joint Stock Company, Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, Vimedimex Medi-Pharma Joint Stock Company, Vietnam Pharmaceutical Corporation, Ha Tay Pharmaceutical Joint Stock Company, among others is a partial list of major market players of the companies responsible for the growth of Vietnam over the counter (OTC) drugs market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Route of Administration

·         Dosage Form

·         Distribution Channel

Regional scope

Northern region, Central region, and Southern region.

Key companies profiled

Sanofi-Aventis Vietnam Company, GlaxoSmithKline Vietnam, Reckitt Benckiser Vietnam, Imexpharm Pharmaceutical Joint Stock Company, DHG Pharmaceutical Joint Stock Company, Traphaco Joint Stock Company, Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, Vimedimex Medi-Pharma Joint Stock Company, Vietnam Pharmaceutical Corporation, Ha Tay Pharmaceutical Joint Stock Company

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Vietnam over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Vietnam Over The Counter (OTC) Drugs Market, By Product:
    • Cough, Cold and Flu
    • Vitamins, Mineral, and Supplements (VMS)
    • Analgesics
    • Gastrointestinal Products
    • Dermatology Products
    • Others
  • Vietnam Over The Counter (OTC) Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
  • Vietnam Over the counter (OTC) drugs Market, By Dosage Form:
    • Tablets
    • Capsules
    • Liquids & Solution
    • Creams/Lotions/Ointments
    • Others
  • Vietnam Over The Counter (OTC) Drugs Market, By Distribution Channel:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • Vietnam Over The Counter (OTC) Drugs Market, By Region:

o   Northern Region

o   Central Region

o   Southern Region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Vietnam over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Vietnam Over The Counter (OTC) Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com 

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Vietnam Over the counter (OTC) drugs (OTC) Drugs Market

4.    Executive Summary

5.    Voice of Customers

6.    Vietnam Over the counter (OTC) drugs (OTC) Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)

6.2.2.     By Route of Administration (Oral, Topical, Parenteral)

6.2.3.     By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    Vietnam Cough, Cold and Flu Over the counter (OTC) drugs (OTC) Drugs Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration

7.2.2.     By Dosage Form

7.2.3.     By Distribution Channel

8.    Vietnam Vitamins, Mineral and Supplements (VMS) Over the counter (OTC) drugs (OTC) Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Route of Administration

8.2.2.     By Dosage Form

8.2.3.     By Distribution Channel

9.    Vietnam Analgesics Over the counter (OTC) drugs (OTC) Drugs Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Route of Administration

9.2.2.     By Dosage Form

9.2.3.     By Distribution Channel

10.  Vietnam Gastrointestinal Over the counter (OTC) drugs (OTC) Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Route of Administration

10.2.2.  By Dosage Form

10.2.3.  By Distribution Channel

11.  Vietnam Dermatology Over the counter (OTC) drugs (OTC) Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Route of Administration

11.2.2.  By Dosage Form

11.2.3.  By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Policy & Regulatory Landscape

15.  Vietnam Economic Profile

16.  Competitive Landscape

16.1.              Competition Outlook

16.2.              Company Profiles

16.2.1.  Sanofi-Aventis Vietnam Company

16.2.2.  GlaxoSmithKline Vietnam

16.2.3.  Reckitt Benckiser Vietnam

16.2.4.  Imexpharm Pharmaceutical Joint Stock Company

16.2.5.  DHG Pharmaceutical Joint Stock Company

16.2.6.  Traphaco Joint Stock Company

16.2.7.  Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company

16.2.8.  Vimedimex Medi-Pharma Joint Stock Company

16.2.9.  Vietnam Pharmaceutical Corporation

16.2.10.                Ha Tay Pharmaceutical Joint Stock Company

Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com